title: Implant removal rate from infection after tibial plateau leveling osteotomy in dogs.
abstract: OBJECTIVE
  To determine implant removal rate associated with infection after tibial plateau leveling osteotomy (TPLO) in dogs and to report antimicrobial susceptibility patterns for isolates.
  
  
  METHODS
  Retrospective case series.
  
  
  METHODS
  Dogs (n = 255; 282 TPLO).
  
  
  METHODS
  Medical records (April 2006-April 2008) for dogs that had TPLO with ≥ 18 month follow-up were reviewed. Dogs that had implant removal with confirmed bacterial isolation from the implant were studied. Cefazolin (22 mg/kg intravenously) was administered before anesthesia induction for TPLO, every 2 hours intraoperatively, and every 6 or 8 hours until the next morning. Antimicrobial susceptibility testing was performed on isolates.
  
  
  RESULTS
  Twenty-one (7.4%) of 282 TPLO required implant removal because of infection. Bacterial species isolated were Actinomyces spp. (1), Corynebacterium spp. (1), Enterococcus spp. (3), hemolytic Staphylococcus coagulase negative (2), nonhemolytic Staphylococcus coagulase negative (3), Staphylococcus spp. coagulase positive (7), methicillin-oxacillin-resistant Staphylococcus coagulase positive (2), and Serratia marcesens (2). Of the antibiotics that had ≥10 isolates tested against them, gentamicin had the highest susceptibility rate (94%), followed by tribrissen (71%), and amoxicillin/clavulanic acid (67%).
  
  
  CONCLUSIONS
  Staphylococcus spp. was reported in 14 of the 21 infections cultured in this study. Based on antimicrobial susceptibility testing, amoxicillin/clavulanic acid would be the best empirical treatment.
authors: Carolina Veterinary Specialists, Charlotte, NC, USA. adgall281@hotmail.com
authors: Alissa D
authors: AD
authors: Gallagher
authors: W Daniel
authors: WD
authors: Mertens
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001860:Bone Plates / Q000009:adverse effects / Q000662:veterinary*; D001863:Bone Screws / Q000009:adverse effects / Q000662:veterinary*; D004283:Dog Diseases / Q000601:surgery*; D004285:Dogs; D024881:Drug Resistance, Bacterial; D005260:Female; D008297:Male; D010027:Osteotomy / Q000379:methods / Q000662:veterinary*; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000662:veterinary*; D012189:Retrospective Studies; D013264:Stifle / Q000601:surgery*
chemical_list: D000900:Anti-Bacterial Agents